HOME >> MEDICINE >> NEWS
Selective and nonselective beta-blockers equally effective in preventing sudden death

DALLAS - September 2, 1999 - A new study from UT Southwestern Medical Center at Dallas should encourage cardiologists to prescribe either selective or nonselective beta-blockers to patients with congestive heart failure. Researchers found both types of drugs equally effective in reducing the risk of sudden death.

In a study of 26 patients with congestive heart failure, researchers from UT Southwestern and Dallas Veterans Affairs Medical Center found no difference in the reduction of QTc dispersion -- a marker of risk for sudden death -- between those treated with selective beta-blockers and those treated with nonselective beta-blockers. Their findings were published in the August issue of The American Journal of Cardiology.

The scientists compared the electrocardiograms (ECG) of the patients before and after three months of therapy with either a selective beta-blocker, which inhibits the beta 1 receptor, or a nonselective beta-blocker, which inhibits both the beta 1 and the beta 2 receptors.

Congestive heart failure kills more than 43,000 people in the United States annually. A number of recent studies have shown that physicians underprescribe beta-blockers because of their side effects despite clinical-trial reports that congestive-heart-failure patients who take them are 43 percent less likely to die during the first two years following a first heart attack than those who do not take them. Side effects may include depression, worsening asthma, tiredness and sexual dysfunction, although many physicians note that the heart attack itself may produce these.

"This is significant because it gives us a better idea of how effective different beta-blockers are in treating congestive heart failure," said Dr. Eric Eichhorn, UT Southwestern professor of internal medicine and director of the cardiac catheterization laboratory at the VA Medical Center. "The findings give doctors more options in treating their patients and help us a
'"/>

Contact: Susan Steeves
susan.steeves@email.swmed.edu
214-648-3404
UT Southwestern Medical Center
31-Aug-1999


Page: 1 2

Related medicine news :

1. Selective coatings create biological sensors from carbon nanotubes
2. Selective inhibitor can target specific enzyme that promotes cancer
3. In heart failure, beta-blockers boost survival advantage for women
4. Wider use of beta-blockers after heart attacks could save thousands of lives at a reasonable cost, new study shows
5. Aspirins potential ability to prevent colon polyps may not apply equally to all
6. New guidelines conclude all aerosol therapy devices equally effective
7. Baby and coated aspirin equally effective in thinning of blood when taken in combination with Plavix
8. Beta-blocker or calcium antagonist-based therapies equally effective in treating hypertension
9. Smoking cessation success equally good with over-the-counter or prescription nicotine replacement
10. Strategy effective against drug resistant tuberculosis
11. Study shows patch therapy may be as effective as oral medications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... The National Business Research ... National Registry of Emergency Medical Technicians and welcomes this organization to the ... Jan G. West, Ph.D. , CEO & Organizational Psychologist at NBRI. “This award ...
(Date:4/26/2017)... ... April 26, 2017 , ... Miami native and local periodontist Dr. John ... have never imagined back in 1991 that this journey would have taken me into ... last 25 years, Dr. Gallardo has pioneered implant dentistry innovation, evolving into an internationally ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more ... CRISPRCas.pioneer.com ) that demonstrates how this advanced plant breeding technology is a more ... with fewer resources. It highlights the business’ principles, research and collaboration efforts in ...
(Date:4/26/2017)... ... April 26, 2017 , ... Bioclinica® ... sponsors and CROs to speed clinical development, has released the industry’s only ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management together ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus Medical, ... the first in a new class of photodynamic cosmetics (PDC). , Allumera® is ... visibly reduce outward signs of aging, and minimize the appearance of pores – ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... VANCOUVER , April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) ... the Bloom Burton & Co. Healthcare Investor Conference 2017 at the ... Edward Wright , Chief Executive Officer of the Company is ... Company,s CFO, Richard Bear and the Chairman of the ... ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 The ... anticipated to showcase a healthy CAGR during the forecast period ... product type in the global digital mobile X-Ray devices market, ... 2,000 Mn in 2017, expanding at a CAGR of 7% ... create absolute $ opportunity of more than US$ 100 Mn ...
Breaking Medicine Technology:
Cached News: